PL332242A1 - Tricyclic inhibitors of proteinous farnesil transferase - Google Patents

Tricyclic inhibitors of proteinous farnesil transferase

Info

Publication number
PL332242A1
PL332242A1 PL97332242A PL33224297A PL332242A1 PL 332242 A1 PL332242 A1 PL 332242A1 PL 97332242 A PL97332242 A PL 97332242A PL 33224297 A PL33224297 A PL 33224297A PL 332242 A1 PL332242 A1 PL 332242A1
Authority
PL
Poland
Prior art keywords
proteinous
tricyclic inhibitors
transferase
farnesil
compounds
Prior art date
Application number
PL97332242A
Other languages
English (en)
Inventor
Arthur G Taveras
Alan K Mallams
Adriano Afonso
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PL332242A1 publication Critical patent/PL332242A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Dental Preparations (AREA)
  • Cereal-Derived Products (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL97332242A 1996-09-13 1997-09-11 Tricyclic inhibitors of proteinous farnesil transferase PL332242A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71332396A 1996-09-13 1996-09-13

Publications (1)

Publication Number Publication Date
PL332242A1 true PL332242A1 (en) 1999-08-30

Family

ID=24865689

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97332242A PL332242A1 (en) 1996-09-13 1997-09-11 Tricyclic inhibitors of proteinous farnesil transferase

Country Status (20)

Country Link
EP (1) EP0929545B1 (OSRAM)
JP (1) JP2001500510A (OSRAM)
KR (1) KR20000036120A (OSRAM)
CN (1) CN1104427C (OSRAM)
AT (1) ATE286046T1 (OSRAM)
AU (1) AU4337997A (OSRAM)
BR (1) BR9712831A (OSRAM)
CA (1) CA2266016C (OSRAM)
CZ (1) CZ84399A3 (OSRAM)
DE (1) DE69732120T2 (OSRAM)
ES (1) ES2235252T3 (OSRAM)
HU (1) HUP0000121A2 (OSRAM)
ID (1) ID21699A (OSRAM)
IL (1) IL128928A0 (OSRAM)
NO (1) NO991234L (OSRAM)
NZ (1) NZ334453A (OSRAM)
PL (1) PL332242A1 (OSRAM)
SK (1) SK33899A3 (OSRAM)
TR (1) TR199901276T2 (OSRAM)
WO (1) WO1998011093A1 (OSRAM)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3962B (en) 1993-12-21 1996-05-27 Albright & Wilson Funcional fluids
US5939416A (en) * 1997-06-17 1999-08-17 Schering Corporation Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6433165B1 (en) 1998-01-21 2002-08-13 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
WO1999037651A1 (en) 1998-01-21 1999-07-29 Millenium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
US8679096B2 (en) 2007-06-21 2014-03-25 Board Of Regents Of The University Of Nebraska Multifunctional operational component for robotic devices
US9579088B2 (en) 2007-02-20 2017-02-28 Board Of Regents Of The University Of Nebraska Methods, systems, and devices for surgical visualization and device manipulation
TW200902007A (en) * 2007-05-25 2009-01-16 Astrazeneca Ab Spirocyclopropyl piperidine derivatives
JP5591696B2 (ja) 2007-07-12 2014-09-17 ボード オブ リージェンツ オブ ザ ユニバーシティ オブ ネブラスカ 生検要素、アーム装置、および医療装置
EP2178431A4 (en) 2007-08-15 2017-01-18 Board of Regents of the University of Nebraska Medical inflation, attachment, and delivery devices and related methods
EP3714821A1 (en) 2011-06-10 2020-09-30 Board of Regents of the University of Nebraska Surgical end effector
CA2841459C (en) 2011-07-11 2020-07-28 Board Of Regents Of The University Of Nebraska Robotic surgical devices, systems, and related methods
EP3730031A1 (en) 2011-10-03 2020-10-28 Board of Regents of the University of Nebraska Robotic surgical devices and systems
WO2013106569A2 (en) 2012-01-10 2013-07-18 Board Of Regents Of The University Of Nebraska Methods, systems, and devices for surgical access and insertion
WO2014011238A2 (en) 2012-05-01 2014-01-16 Board Of Regents Of The University Of Nebraska Single site robotic device and related systems and methods
EP3943255B1 (en) 2012-06-22 2023-06-14 Board of Regents of the University of Nebraska Local control robotic surgical devices
US9770305B2 (en) 2012-08-08 2017-09-26 Board Of Regents Of The University Of Nebraska Robotic surgical devices, systems, and related methods
WO2014025399A1 (en) 2012-08-08 2014-02-13 Board Of Regents Of The University Of Nebraska Robotic surgical devices, systems, and related methods
US9888966B2 (en) 2013-03-14 2018-02-13 Board Of Regents Of The University Of Nebraska Methods, systems, and devices relating to force control surgical systems
CA2905948C (en) 2013-03-14 2022-01-11 Board Of Regents Of The University Of Nebraska Methods, systems, and devices relating to robotic surgical devices, end effectors, and controllers
CA2906772C (en) 2013-03-15 2021-09-21 Board Of Regents Of The University Of Nebraska Robotic surgical devices, systems and related methods
US10966700B2 (en) 2013-07-17 2021-04-06 Virtual Incision Corporation Robotic surgical devices, systems and related methods
WO2016040946A1 (en) 2014-09-12 2016-03-17 Board Of Regents Of University Of Nebraska Quick-release end effectors and related systems and methods
EP4286104A3 (en) 2014-11-11 2024-02-14 Board of Regents of the University of Nebraska Robotic device with compact joint design and related systems and methods
CN114027986B (zh) 2015-08-03 2024-06-14 内布拉斯加大学董事会 机器人手术装置系统及相关方法
JP7176757B2 (ja) 2016-05-18 2022-11-22 バーチャル インシジョン コーポレイション ロボット手術装置、システム及び関連する方法
EP3503829A4 (en) 2016-08-25 2020-04-15 Board of Regents of the University of Nebraska Quick-release tool coupler and related systems and methods
EP3507065B1 (en) 2016-08-30 2025-02-12 Board of Regents of the University of Nebraska Robotic device with compact joint design and an additional degree of freedom
EP3544539A4 (en) 2016-11-22 2020-08-05 Board of Regents of the University of Nebraska ENHANCED COARSE POSITIONING DEVICE AND RELATED SYSTEMS AND PROCESSES
JP7099728B2 (ja) 2016-11-29 2022-07-12 バーチャル インシジョン コーポレイション ユーザの存在検出機能を備えたユーザコントローラ、関連システムおよび方法
WO2018112199A1 (en) 2016-12-14 2018-06-21 Virtual Incision Corporation Releasable attachment device for coupling to medical devices and related systems and methods
JP7405432B2 (ja) 2017-09-27 2023-12-26 バーチャル インシジョン コーポレイション 追跡カメラ技術を有するロボット手術デバイスならびに関連するシステムおよび方法
WO2019136360A1 (en) 2018-01-05 2019-07-11 Board Of Regents Of The University Of Nebraska Single-arm robotic device with compact joint design and related systems and methods
US11903658B2 (en) 2019-01-07 2024-02-20 Virtual Incision Corporation Robotically assisted surgical system and related devices and methods
WO2022010887A1 (en) 2020-07-06 2022-01-13 Virtual Incision Corporation Surgical Robot Positioning System and Related Devices and Methods

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
US4826853A (en) * 1986-10-31 1989-05-02 Schering Corporation 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
KR920014799A (ko) * 1991-01-18 1992-08-25 나오가따 다이도 신규벤조[5,6]시클로헵타[1,2-b]피리딘 유도체 및 이를 함유하는 항알레르기제
IL111257A0 (en) * 1993-10-15 1994-12-29 Schering Corp Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
AU699043B2 (en) * 1993-10-15 1998-11-19 Schering Corporation Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US5700806A (en) * 1995-03-24 1997-12-23 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
TW350844B (en) * 1995-12-22 1999-01-21 Schering Corp Tricyclic amides useful to inhibition of G-protein function and for treatment of proliferative diseases

Also Published As

Publication number Publication date
CZ84399A3 (cs) 1999-11-17
NO991234L (no) 1999-05-12
BR9712831A (pt) 1999-11-16
WO1998011093A1 (en) 1998-03-19
NO991234D0 (no) 1999-03-12
IL128928A0 (en) 2000-02-17
DE69732120D1 (de) 2005-02-03
ATE286046T1 (de) 2005-01-15
CA2266016A1 (en) 1998-03-19
NZ334453A (en) 2000-08-25
ES2235252T3 (es) 2005-07-01
EP0929545A1 (en) 1999-07-21
CN1237165A (zh) 1999-12-01
JP2001500510A (ja) 2001-01-16
CA2266016C (en) 2004-06-01
AU4337997A (en) 1998-04-02
HUP0000121A2 (hu) 2001-04-28
TR199901276T2 (xx) 1999-09-21
DE69732120T2 (de) 2005-12-08
SK33899A3 (en) 2000-02-14
KR20000036120A (ko) 2000-06-26
ID21699A (id) 1999-07-15
CN1104427C (zh) 2003-04-02
EP0929545B1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
PL332242A1 (en) Tricyclic inhibitors of proteinous farnesil transferase
PL332192A1 (en) Compounds useful in inhibiting proteinous farnesil transferase
PL332253A1 (en) Derivatives of subtituted benzocycloheptapyridine useful in inhibiting proteinous farnesil transferase
PL332279A1 (en) Compounds suitable to inhibit proteinous farnesil transferase
PL332319A1 (en) Substitution bezocycloheptapyridine derivatives useful in inhibiting protweinous farnesil transferase
MY117925A (en) Compounds for the inhibition of farnesyl protein transferase.
IL133447A0 (en) Compounds useful for inhibition of farnesyl protein transferase